Patient Preferences for Leadless Pacemakers
Recruiting at14 trial locations
SR
Overseen byShelby Reed, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Abbott Medical Devices
No Placebo Group
Trial Summary
What is the purpose of this trial?
Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers
Research Team
SR
Shelby Reed, PhD
Principal Investigator
Duke Clinical Research Institute
Eligibility Criteria
Inclusion Criteria
Able to read and speak English to consent to participate in the survey
Willing and able to use a tablet or computer to complete the survey
Scheduled to undergo evaluation for a de novo cardiac pacemaker at the study site (patient may or may not have a known indication for a pacemaker at the time)
Treatment Details
Interventions
- Leadless Pacemaker (Procedure)
- Transvenous Pacemaker (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abbott Medical Devices
Lead Sponsor
Trials
659
Recruited
420,000+
Founded
1888
Headquarters
Abbott Park, Illinois, USA
Known For
Medical Devices Innovation
Top Products
FreeStyle Libre, MitraClip, XIENCE Stents, TECNIS IOLs
Dr. Etahn Korngold
Abbott Medical Devices
Chief Medical Officer
Medical training at Harvard Medical School and Massachusetts General Hospital
Robert B. Ford
Abbott Medical Devices
Chief Executive Officer since 2020
Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business